A Comparison of Tolerability of 10 Inhalations of Symbicort Turbuhaler 160/4.5 microg and 10 Inhalations of Terbutaline Turbuhaler 0.4 mg on Top of Symbicort Turbuhaler 160/4.5 mg 1 Inhalation Bid, Randomized, Double-Blind, Cross Over, Phase III Study in Japanese Adults Asthma Patients.
Phase of Trial: Phase III
Latest Information Update: 22 Dec 2016
At a glance
- Drugs Budesonide/formoterol (Primary) ; Terbutaline
- Indications Asthma
- Focus Adverse reactions; Pharmacokinetics
- Sponsors AstraZeneca
- 18 May 2011 Tolerability results presented at the 107th International Conference of the American Thoracic Society.
- 09 Sep 2009 Actual patient number (25) added as reported by ClinicalTrials.gov.
- 09 Sep 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.